2006年4月
Matrix metalloproteinase-1 and-9 promoter polymorphisms are not associated with an increased risk of uterine leiomyomas in a Japanese population
JOURNAL OF THE SOCIETY FOR GYNECOLOGIC INVESTIGATION
- ,
- ,
- ,
- ,
- ,
- 巻
- 13
- 号
- 3
- 開始ページ
- 232
- 終了ページ
- 236
- 記述言語
- 英語
- 掲載種別
- DOI
- 10.1016/j.jsgi.2006.02.004
- 出版者・発行元
- ELSEVIER SCIENCE INC
OBJECTIVE: Matrix metalloproteinases (MMPs) play are important role in modeling and remodeling the extracellular matrix in leiomyomas. Hence, the investigated whether associations exist between leiomyomas and promoter polymorphisms in the MMP-1 and MMP-9 genes in a Japanese population.
METHODS: We compared the distribution of polymorphisms in the promoter regions of MMP-1 (-1607 1G/2G) and MMP-9 (-1562 C/T) in 267 leiomyoma patients and 184 control patients using polymerase chain reaction-fragment-length polymorphism (PCP-RFLP) analysis.
RESULTS: The allele frequencies of the MMP-1 - 1607 2G and MMP-9 - 1562 T polymorphisms were 74.6% and 18.6% in leiomyoma patients, anal 71.3% and 18.6% in control patients, respectively. No signs scant differences in allele frequencies or genotype distributions were found between leiomyoma and control patients. Moreover, no associations were found between MMP-1 and MMP-9 genotypes and leiomyoma size or a family history of the condition.
CONCLUSION: These findings suggest that MMP-1 and MMP-9 promoter polymorphisms are unlikely to be associated with an increased risk of uterine leiomyomas in Japanese women.
METHODS: We compared the distribution of polymorphisms in the promoter regions of MMP-1 (-1607 1G/2G) and MMP-9 (-1562 C/T) in 267 leiomyoma patients and 184 control patients using polymerase chain reaction-fragment-length polymorphism (PCP-RFLP) analysis.
RESULTS: The allele frequencies of the MMP-1 - 1607 2G and MMP-9 - 1562 T polymorphisms were 74.6% and 18.6% in leiomyoma patients, anal 71.3% and 18.6% in control patients, respectively. No signs scant differences in allele frequencies or genotype distributions were found between leiomyoma and control patients. Moreover, no associations were found between MMP-1 and MMP-9 genotypes and leiomyoma size or a family history of the condition.
CONCLUSION: These findings suggest that MMP-1 and MMP-9 promoter polymorphisms are unlikely to be associated with an increased risk of uterine leiomyomas in Japanese women.
- リンク情報
- ID情報
-
- DOI : 10.1016/j.jsgi.2006.02.004
- ISSN : 1071-5576
- Web of Science ID : WOS:000237372500014